Jim Simons Ocuphire Pharma, Inc. Transaction History

Renaissance Technologies LLC

$63.1 Billion
Q3 2024

A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Renaissance Technologies LLC holds 70,609 shares of OCUP stock, worth $69,196. This represents 0.0% of its overall portfolio holdings.

Number of Shares

70,609

Previous 41,700 69.33%

Holding current value

$69,196

Previous $63,000 46.03%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$1.19 - $2.07 $34,401 - $59,841	28,909 Added 69.33%	70,609 $92,000
Q2 2024 Aug 09, 2024	SELL	$1.51 - $2.23 $141,336 - $208,728	-93,600 Reduced 69.18%	41,700 $63,000
Q1 2024 May 13, 2024	BUY	$1.89 - $3.27 $209,931 - $363,215	111,075 Added 458.51%	135,300 $272,000
Q4 2023 Feb 13, 2024	BUY	$2.59 - $3.64 $62,742 - $88,179	24,225 New	24,225 $73,000
Q2 2023 Aug 11, 2023	SELL	$3.63 - $6.38 $328,039 - $576,554	-90,369 Reduced 47.57%	99,600 $432,000
Q1 2023 May 12, 2023	BUY	$3.01 - $3.85 $1,411 - $1,805	469 Added 0.25%	189,969 $712,000
Q4 2022 Feb 13, 2023	SELL	$2.04 - $3.53 $35,498 - $61,425	-17,401 Reduced 8.41%	189,500 $669,000
Q3 2022 Nov 14, 2022	BUY	$1.82 - $2.79 $15,854 - $24,303	8,711 Added 4.4%	206,901 $416,000
Q2 2022 Aug 12, 2022	BUY	$1.8 - $3.25 $356,742 - $644,117	198,190 New	198,190 $381,000
Q1 2022 May 13, 2022	SELL	$2.75 - $4.39 $53,242 - $84,994	-19,361 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$3.4 - $5.19 $65,827 - $100,483	19,361 New	19,361 $72,000
Q3 2021 Nov 12, 2021	SELL	$3.84 - $5.38 $136,431 - $191,146	-35,529 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$4.24 - $6.57 $331,105 - $513,057	-78,091 Reduced 68.73%	35,529 $188,000
Q1 2021 May 13, 2021	BUY	$5.7 - $13.31 $226,860 - $529,738	39,800 Added 53.91%	113,620 $660,000
Q4 2020 Feb 10, 2021	BUY	$3.76 - $8.8 $277,563 - $649,616	73,820 New	73,820 $479,000

Others Institutions Holding OCUP

# of Institutions

Shares Held

2.58M

Call Options Held

14.1K

Put Options Held

800

View Full List

About Ocuphire Pharma, Inc.

Ticker OCUP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,579,800
Market Cap $20.2M
Description
Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...

More about OCUP

Track Jim Simons's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.

Account